Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis

Blood Cells, Molecules, and Diseases

Volumn 41, Issue 1, 2008, Pages 5-9

  Rocha, Susana ^a,b   Vitorino, Rui M P ^c   Lemos Amado, Francisco M ^c   Castro, Elisabeth Bayer ^a,b   Rocha Pereira, Petronila ^b,d   Barbot, José ^e   Cleto, Esmeralda ^f   Ferreira, Fátima ^g   Quintanilha, Alexandre ^b   Belo, Luís ^a,b   Santos Silva, Alice ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF AVEIRO   (Portugal)

^d UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^e HOSPITAL MARIA PIA   (Portugal)

^f HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^g HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Erythrocyte membrane proteins; Hereditary spherocytosis; Mass spectroscopy; Oxidative stress; Peroxiredoxin 2

Indexed keywords

HEMOGLOBIN; PEROXIREDOXIN; PEROXIREDOXIN 2;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; ERYTHROCYTE; HEREDITARY SPHEROCYTOSIS; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ERYTHROCYTE MEMBRANE; HEMOGLOBINS; HUMANS; OXIDATIVE STRESS; PEROXIREDOXINS; SPHEROCYTOSIS, HEREDITARY;

EID: 44449117859     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2008.02.008     Document Type: Article

References (42)

1. Delaunay J. The molecular basis of hereditary red cell membrane disorders. Blood Rev. 21 1 (2007) 1-20
2. Bolton-Maggs P.H.B., Stevens R.F., Dodd N.J., et al. Guidelines for the diagnosis and management of hereditary spherocytosis. Br. J. Haematol. 126 (2004) 455-474
3. + transport in erythrocyte membrane vesicles requires a cytoplasmic protein. J. Biol. Chem. 266 (1991) 18964-18968
4. Rabilloud T., Berthier R., Vinçon M., et al. Early events in erythroid differentiation: accumulation of the acidic peroxidoxin (PRP/TSA/NKEF-B). Biochem. J. 312 (1995) 699-705
5. Schröder E., Littlechild J.A., Lebedev A.A., et al. Crystal structure of decameric 2-cys peroxiredoxinfrom human erythrocytes at 1.7 A° resolution. Structure 8 (2000) 605-615
6. Wood Z.A., Schröder E., Harris J.R., and Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28 (2003) 32-40
7. Cha M.K., and Kim I.H. Thioredoxin-linked peroxidade from human red blood cell: evidence for the existence of thioredoxin and thioredoxin reductase in human red blood cell. Biochem. Biophys. Res. Commun. 217 3 (1995) 900-907
8. Harris J.R., Schröder E., Isupov M.N., et al. Comparison of the decameric structure of peroxiredoxin-II by transmission electron microscopy and X-ray crystallography. Biochim. Biophys. Acta 1547 (2001) 221-234
9. Kristensen P., Rasmussen D.E., and Kristensen B.I. Properties of thiol-specific anti-oxidant protein or calpromotin in solution. Biochem. Biophys. Res. Commun. 262 (1999) 127-131
10. Schröder E., Willis A.C., and Ponting C.P. Porcine natural-killer enhancing factor-B: oligomerization and identification as a calpain substrate in vitro. Biochim. Biophys. Acta 1384 (1998) 279-291
11. Cha M.K., Yun C.H., and Kim I.H. Interaction of human thiol-specific antioxidant protein 1 with erythrocyte plasma membrane. Biochemistry 39 (2000) 6944-6950
12. Moore R.B., Shriver S.K., Jenkins L.D., et al. Calpromotin, a cytoplasmic protein, is associated with the formation of dense cells in sickle cell anemia. Am. J. Hematol. 56 (1997) 100-106
13. Plishker G.A., Chevalier D., Seinsoth L., and Moore R.B. Calcium activated potassium transport and high molecular weight forms of calpromotin. J. Biol. Chem. 267 (1992) 21839-21843
14. Murphy S.C., Samuel B.U., Harrison T., et al. Erythrocyte detergent-resistant membrane proteins: their characterization and selective uptake during malarial infection. Blood 103 5 (2004) 1920-1928
15. Kay M.M.B. Role of physiologic autoantibody in the removal of senescent human red cells. J. Supramol. Struct. 9 (1978) 555-567
16. Kay M.M.B., Goodman S.R., Sorensen K., et al. Senescent cell antigen is immunologically related to band 3. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 1631-1635
17. Kay M.M.B. Localization of senescent cell antigen on band 3. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 5753-5757
18. Lutz H.U., Bussolino F., Flepp R., et al. Naturally occurring anti-band 3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 7368-7372
19. Lutz A. Naturally occurring anti-band 3 antibodies. Transfus. Med. Rev. 6 (1992) 201-211
20. International Committee for Standardization in Haematology. ICSH reference method for staining of blood and bone marrow films by azure B and eosin Y (Romanowsky stain). Br. J. Haematol. 57 (1984) 707-710
21. Roper D., Layton M., and Lewis S.M. Investigation of the hereditary hemolytic anemias: membrane and enzyme abnormalities. In: Lewis S.M., Bain B.J., and Bates I. (Eds). Dacie and Lewis Practical Haematology (2001), Churchill Livingstone, London 167-198
22. Regan F., Newlands M., and Bain B.J. Acquired haemolytic anaemias. In: Lewis S.M., Bain B.J., and Bates I. (Eds). Dacie and Lewis Practical Haematology (2001), Churchill Livingstone, London 199-229
23. Dodge J.T., Mitchell C., and Hanahan D.J. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem. Biophys. 100 (1963) 119-130
24. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of the protein-dye binding. Anal. Biochem. 72 (1976) 248-254
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T. Nature 227 (1970) 680-685
26. Fairbanks G., Steck T.L., and Wallach D.F.H. Electrophoresis of the major polypeptides of the human erythocyte membrane. Biochemistry 10 (1971) 2606-2616
27. Gallagher P.G., Tse W.T., and Forget B.G. Clinical and molecular aspects of disorders of the erythrocyte membrane skeleton. Semin. Perinatol. 14 5 (1990) 352-367
28. Towbin H., Stahelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76 9 (1979) 4350-4354
29. Santos-Silva A., Castro E.M.B., Teixeira N.A., et al. Altered erythrocyte membrane band 3 profile as a marker in patients at risk for cardiovascular disease. Atherosclerosis 116 2 (1995) 199-209
30. Margetis P., Antonelou M., Karababa F., et al. Physiologically important secondary modifications of red cell membrane in hereditary spherocytosis - evidence for in vivo oxidation and lipid raft protein modifications. Blood Cells Mol. Dis. 38 3 (2007) 210-220
31. Lee T.-H., Kim S.-U., Yu S.-L., et al. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 101 12 (2003) 5033-5038
32. C.A. Neumann, D.S. Krause, C.V. Carman, et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defense and tumor suppression, Nature 424 (2003) 561-565.
33. Rocha S., Rebelo I., Costa E., et al. Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis. Eur. J. Haematol. 74 (2005) 374-380
34. Low F.M., Hampton M.B., Peskin A.V., and Winterbourn C.C. Peroxiredoxin 2 function as a non-catalytic scavenger of low level hydrogen peroxide in the erythrocyte. Blood 109 6 (2007) 2611-2617
35. 2 levels in erythrocytes. Free Radic. Biol. Med. 39 (2005) 1407-1417
36. Stuhlmeier K.M., Kao J.J., Wallbrant P., et al. Antioxidant protein 2 prevents methemoglobin formation in erythrocyte hemolysates. Eur. J. Biochemistry 270 (2003) 334-341
37. Low P.S., Waugh S.M., Zinke K., and Drenckhahn D. The role of hemoglobin denaturation and band 3 clustering in red blood cell aging. Science 227 (1985) 531-533
38. Santos-Silva A., Rebelo I., Castro E.M.B., et al. Leukocyte activation, erythrocyte damage, lipid profile and oxidative stress imposed by high competition physical exercise in adolescents. Clin. Chim. Acta 306 1-2 (2001) 119-126
39. Santos-Silva A., Rebelo I., Castro E., et al. Erythrocyte damage and leukocyte activation in ischemic stroke. Clin. Chim. Acta 320 (2002) 29-35
40. Belo L., Rebelo I., Castro E.M.B., et al. Band 3 as a marker of erythrocyte changes in pregnancy. Eur. J. Haematol. 69 3 (2002) 145-151
41. Rocha-Pereira P., Santos-Silva A., Rebelo I., et al. Erythrocyte damage in mild and severe psoriasis. Br. J. Dermatology 150 2 (2004) 232-244
42. Santos-Silva A., Castro E.M.B., Teixeira N.A., et al. Erythrocyte membrane band 3 profile imposed by cellular aging, by activated neutrophils and by neutrophilic elastase. Clin. Chim. Acta 275 (1998) 185-196